Evotec SE Statistics
Total Valuation
Evotec SE has a market cap or net worth of $1.40 billion. The enterprise value is $1.52 billion.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, before market open.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Evotec SE has 177.53 million shares outstanding. The number of shares has increased by 0.18% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 177.53M |
| Shares Change (YoY) | +0.18% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 130.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.64 |
| Forward PS | 2.11 |
| PB Ratio | 1.42 |
| P/TBV Ratio | 2.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 37.48 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.79 |
| EV / EBITDA | 1,210.91 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.52.
| Current Ratio | 2.03 |
| Quick Ratio | 1.75 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 21.09 |
| Debt / FCF | n/a |
| Interest Coverage | -7.04 |
Financial Efficiency
Return on equity (ROE) is -20.51% and return on invested capital (ROIC) is -3.22%.
| Return on Equity (ROE) | -20.51% |
| Return on Assets (ROA) | -2.42% |
| Return on Invested Capital (ROIC) | -3.22% |
| Return on Capital Employed (ROCE) | -5.07% |
| Revenue Per Employee | $179,735 |
| Profits Per Employee | -$47,197 |
| Employee Count | 4,740 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 20.84 |
Taxes
In the past 12 months, Evotec SE has paid $10.74 million in taxes.
| Income Tax | 10.74M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.49% in the last 52 weeks. The beta is 1.09, so Evotec SE's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -11.49% |
| 50-Day Moving Average | 4.08 |
| 200-Day Moving Average | 4.02 |
| Relative Strength Index (RSI) | 52.74 |
| Average Volume (20 Days) | 128,313 |
Short Selling Information
| Short Interest | 785,225 |
| Short Previous Month | 767,711 |
| Short % of Shares Out | 0.22% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.04 |
Income Statement
In the last 12 months, Evotec SE had revenue of $851.94 million and -$223.72 million in losses. Loss per share was -$1.27.
| Revenue | 851.94M |
| Gross Profit | 116.03M |
| Operating Income | -87.04M |
| Pretax Income | n/a |
| Net Income | -223.72M |
| EBITDA | 1.26M |
| EBIT | -87.04M |
| Loss Per Share | -$1.27 |
Full Income StatementBalance Sheet
The company has $401.47 million in cash and $517.41 million in debt, giving a net cash position of -$115.94 million or -$0.65 per share.
| Cash & Cash Equivalents | 401.47M |
| Total Debt | 517.41M |
| Net Cash | -115.94M |
| Net Cash Per Share | -$0.65 |
| Equity (Book Value) | 985.89M |
| Book Value Per Share | 5.55 |
| Working Capital | 396.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $37.39 million and capital expenditures -$103.14 million, giving a free cash flow of -$71.31 million.
| Operating Cash Flow | 37.39M |
| Capital Expenditures | -103.14M |
| Free Cash Flow | -71.31M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 13.62%, with operating and profit margins of -10.22% and -26.26%.
| Gross Margin | 13.62% |
| Operating Margin | -10.22% |
| Pretax Margin | -25.00% |
| Profit Margin | -26.26% |
| EBITDA Margin | 0.15% |
| EBIT Margin | -10.22% |
| FCF Margin | n/a |
Dividends & Yields
Evotec SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.18% |
| Shareholder Yield | -0.18% |
| Earnings Yield | -15.97% |
| FCF Yield | -5.09% |
Dividend DetailsAnalyst Forecast
The average price target for Evotec SE is $5.90, which is 41.83% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.90 |
| Price Target Difference | 41.83% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 9.96% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 20, 2021. It was a forward split with a ratio of 4:1.
| Last Split Date | Oct 20, 2021 |
| Split Type | Forward |
| Split Ratio | 4:1 |
Scores
Evotec SE has an Altman Z-Score of 0.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.84 |
| Piotroski F-Score | 4 |
